Augustine Therapeutics
$83.3M
Funding date
Valuation / Funding
No funding history available
Funding data has not been imported for this company yet
Current Valuation Metrics
Augustine Therapeutics is currently valued at $73.5M as of March 24, 2025. The company has raised a total of $93.4M in funding.
Capital Efficiency
With a capital efficiency ratio of 0.79x, Augustine Therapeutics has achieved a valuation that is 0.79 times the total capital raised. This metric indicates room for improvement in capital deployment.
Investment Perspective
Augustine Therapeutics's valuation reflects investor confidence in the company's market position, growth potential, and ability to execute on its business model. Private market valuations are determined by primary funding rounds and secondary market transactions, which take into account financial performance, market conditions, and growth prospects.
What is Augustine Therapeutics Worth in 2025?
As of 2025, Augustine Therapeutics is valued at $73.5M, based on the company's Later Stage VC funding round in March 24, 2025. This valuation positions Augustine Therapeutics as one of the leading private companies in the sector.
Augustine Therapeutics Valuation History
Augustine Therapeutics's funding history demonstrates steady growth and investor confidence.
How Augustine Therapeutics Valuation is Determined
Private company valuations like Augustine Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including:
- Revenue growth and financial performance
- Market opportunity and total addressable market (TAM)
- Competitive positioning and market share
- Management team strength and execution capability
- Technology and intellectual property
- Industry trends and investor sentiment
Augustine Therapeutics Valuation FAQs
Is Augustine Therapeutics profitable?
Augustine Therapeutics has not publicly disclosed its profitability status. Many high-growth private companies prioritize market expansion and user growth over profitability in their early stages.
How does Augustine Therapeutics's valuation compare to competitors?
Augustine Therapeutics is valued at $73.5M, positioning it as a major player in the space. Secondary market pricing and private market transactions provide ongoing validation of this valuation.
When will Augustine Therapeutics IPO?
Augustine Therapeutics has not announced plans for an initial public offering. Until an IPO, investors can access Augustine Therapeutics shares through secondary market platforms.